XML 76 R65.htm IDEA: XBRL DOCUMENT v3.25.3
Identifiable Intangible Assets, Net and Goodwill - Schedule of Finite-lived and Indefinite-lived Intangible Assets (Detail) - USD ($)
$ in Millions
Sep. 28, 2025
Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount $ 104,849 $ 103,397
Finite-lived intangible assets, accumulated amortization [1] (71,337) (67,549)
Finite-lived intangible assets, net 33,513 35,848
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 17,811 19,563
Intangible assets, gross carrying amount [1] 122,660 122,961
Finite-lived intangible assets, accumulated amortization [1] (71,337) (67,549)
Identifiable Intangible Assets, less Accumulated Amortization [1] 51,324 55,411
IPR&D [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets [2],[3] 17,350 18,893
License Agreements and Other [Member]    
Indefinite-lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets [4] 461 670
Developed technology rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount [3] 101,220 99,397
Finite-lived intangible assets, accumulated amortization [3] (69,057) (65,044)
Finite-lived intangible assets, net [3] 32,163 34,353
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization [3] (69,057) (65,044)
Brands [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount 1,274 1,277
Finite-lived intangible assets, accumulated amortization (1,023) (992)
Finite-lived intangible assets, net 251 285
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization (1,023) (992)
License Agreements and Other [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross carrying amount 2,355 2,724
Finite-lived intangible assets, accumulated amortization (1,256) (1,513)
Finite-lived intangible assets, net 1,099 1,210
Indefinite-lived Intangible Assets [Line Items]    
Finite-lived intangible assets, accumulated amortization $ (1,256) $ (1,513)
[1] The decrease is primarily due to amortization expense of $3.6 billion.
[2] The decrease in the gross carrying amount reflects an impairment of $260 million (see Note 4).
[3] The changes in the gross carrying amounts primarily reflect the transfer of $600 million and $590 million from IPR&D to developed technology rights for Padcev and talazoparib (Talzenna), respectively, as well as the impact of foreign exchange.
[4] The decrease in the gross carrying amount reflects an impairment of $210 million (see Note 4).